TARA is trading at $3.85 (3.8% down) in pre-market, easing back after recent low-float biotech-driven volatility.
- The stock is experiencing a normal pullback following an 8.5% surge on June 23, 2026, which was driven by trading dynamics rather than company-specific news.
- Today's downward move comes as momentum cools for the biotech firm amid a broadly mixed market backdrop.